TNPO3
Basic information
Region (hg38): 7:128954180-129055173
Previous symbols: [ "LGMD1F" ]
Links
Phenotypes
GenCC
Source:
- autosomal dominant limb-girdle muscular dystrophy type 1F (Strong), mode of inheritance: AD
- autosomal dominant limb-girdle muscular dystrophy type 1F (Supportive), mode of inheritance: AD
- autosomal dominant limb-girdle muscular dystrophy type 1F (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Muscular dystrophy, limb-girdle, autosomal dominant 2 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 11222786; 23543484; 23667635 |
ClinVar
This is a list of variants' phenotypes submitted to
- Autosomal dominant limb-girdle muscular dystrophy type 1F (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNPO3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 113 | 131 | |||
missense | 239 | 243 | ||||
nonsense | 8 | |||||
start loss | 2 | |||||
frameshift | 13 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 9 | |||||
splice region | 12 | 17 | 3 | 32 | ||
non coding | 10 | 107 | 39 | 156 | ||
Total | 1 | 7 | 285 | 223 | 46 |
Variants in TNPO3
This is a list of pathogenic ClinVar variants found in the TNPO3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-128957252-GAGCTATCGAA-G | Autosomal dominant limb-girdle muscular dystrophy type 1F | Uncertain significance (May 25, 2022) | ||
7-128957255-CT-C | Autosomal dominant limb-girdle muscular dystrophy type 1F | Pathogenic (May 07, 2013) | ||
7-128957259-C-T | not specified • Autosomal dominant limb-girdle muscular dystrophy type 1F | Uncertain significance (Oct 04, 2022) | ||
7-128957259-CG-C | Autosomal dominant limb-girdle muscular dystrophy type 1F | Likely pathogenic (Mar 09, 2022) | ||
7-128957262-A-G | Autosomal dominant limb-girdle muscular dystrophy type 1F | Uncertain significance (Mar 12, 2022) | ||
7-128957266-AC-A | Likely pathogenic (Oct 01, 2021) | |||
7-128957271-G-A | Inborn genetic diseases | Uncertain significance (Jan 30, 2024) | ||
7-128957272-TG-T | Autosomal dominant limb-girdle muscular dystrophy type 1F | Uncertain significance (Dec 12, 2022) | ||
7-128957276-G-T | Autosomal dominant limb-girdle muscular dystrophy type 1F | Uncertain significance (Dec 07, 2023) | ||
7-128957286-G-A | Autosomal dominant limb-girdle muscular dystrophy type 1F • TNPO3-related disorder | Conflicting classifications of pathogenicity (Apr 01, 2024) | ||
7-128957309-C-T | Autosomal dominant limb-girdle muscular dystrophy type 1F | Conflicting classifications of pathogenicity (Jan 04, 2023) | ||
7-128957533-T-G | Benign (Jun 14, 2018) | |||
7-128957582-T-C | Likely benign (Nov 10, 2018) | |||
7-128966993-C-T | Likely benign (Aug 03, 2018) | |||
7-128967262-AC-A | Autosomal dominant limb-girdle muscular dystrophy type 1F | Benign (Aug 10, 2023) | ||
7-128967263-C-G | Autosomal dominant limb-girdle muscular dystrophy type 1F | Likely benign (Feb 25, 2023) | ||
7-128967264-C-A | Autosomal dominant limb-girdle muscular dystrophy type 1F | Likely benign (Apr 21, 2023) | ||
7-128967269-G-T | Autosomal dominant limb-girdle muscular dystrophy type 1F | Likely benign (Sep 30, 2022) | ||
7-128967283-G-C | Inborn genetic diseases | Uncertain significance (May 20, 2024) | ||
7-128967285-G-C | Autosomal dominant limb-girdle muscular dystrophy type 1F | Likely benign (Nov 18, 2023) | ||
7-128967314-T-G | Autosomal dominant limb-girdle muscular dystrophy type 1F | Uncertain significance (Oct 07, 2021) | ||
7-128967315-G-C | Uncertain significance (Feb 02, 2017) | |||
7-128967317-G-A | Autosomal dominant limb-girdle muscular dystrophy type 1F | Uncertain significance (Aug 03, 2021) | ||
7-128967317-G-T | Autosomal dominant limb-girdle muscular dystrophy type 1F | Uncertain significance (Jul 12, 2022) | ||
7-128967318-T-C | Autosomal dominant limb-girdle muscular dystrophy type 1F | Likely benign (Nov 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TNPO3 | protein_coding | protein_coding | ENST00000265388 | 22 | 100251 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000175 | 1.00 | 125704 | 0 | 44 | 125748 | 0.000175 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.44 | 300 | 521 | 0.576 | 0.0000286 | 6015 |
Missense in Polyphen | 58 | 131.76 | 0.44021 | 1481 | ||
Synonymous | 0.983 | 173 | 190 | 0.909 | 0.00000979 | 1826 |
Loss of Function | 4.56 | 21 | 58.7 | 0.358 | 0.00000355 | 610 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000177 | 0.000177 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000187 | 0.000185 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000197 | 0.000196 |
Other | 0.000329 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Seems to function in nuclear protein import as nuclear transport receptor. In vitro, mediates the nuclear import of splicing factor SR proteins RBM4, SFRS1 and SFRS2, by recognizing phosphorylated RS domains. {ECO:0000269|PubMed:10366588, ECO:0000269|PubMed:10713112, ECO:0000269|PubMed:11517331, ECO:0000269|PubMed:12628928}.;
Recessive Scores
- pRec
- 0.114
Intolerance Scores
- loftool
- 0.301
- rvis_EVS
- -1.18
- rvis_percentile_EVS
- 5.94
Haploinsufficiency Scores
- pHI
- 0.608
- hipred
- Y
- hipred_score
- 0.526
- ghis
- 0.664
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.867
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tnpo3
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- tnpo3
- Affected structure
- thymus
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- protein import into nucleus
- Cellular component
- nucleus;cytoplasm;intracellular membrane-bounded organelle
- Molecular function
- protein binding;protein transporter activity;signaling receptor activity;identical protein binding